Chemistry: analytical and immunological testing – Involving immune complex formed in liquid phase – Signal modification or steric inhibition
Patent
1989-04-11
1994-08-09
Ceperley, Mary E.
Chemistry: analytical and immunological testing
Involving immune complex formed in liquid phase
Signal modification or steric inhibition
436546, 436815, 544209, G01N 33542, C07D40514
Patent
active
053366220
ABSTRACT:
A fluorescence polarization immunoassay for flecainide and tracers therefor are disclosed.
REFERENCES:
patent: 3900481 (1975-08-01), Banitt et al.
patent: 4255329 (1981-03-01), Ullman
patent: 4351760 (1982-09-01), Khanna et al.
patent: 4420568 (1983-12-01), Wang et al.
patent: 4476228 (1984-10-01), Huchzermeier et al.
patent: 4476229 (1984-10-01), Fino et al.
patent: 4481136 (1984-11-01), Khanna et al.
patent: 4492762 (1985-01-01), Wang et al.
patent: 4510251 (1985-04-01), Kirkemo et al.
patent: 4585862 (1986-04-01), Wang et al.
patent: 4588697 (1986-05-01), Khanna et al.
patent: 4593089 (1986-06-01), Wang et al.
patent: 4681859 (1987-07-01), Kramer
Colbert, et al., Clin. Chem., 30(11):1765-1769 (1984).
Johnson, et al., FEBS Letters, 132(2):252-256 (Sep. 1981).
Shipchandler, et al., Analytical Biochemistry, 162:89-101 (1987).
Abbott Laboratories
Ceperley Mary E.
Collins Daniel W.
Steele Gregory W.
LandOfFree
Tracers for use in flecainide fluorescence polarization immunoas does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tracers for use in flecainide fluorescence polarization immunoas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tracers for use in flecainide fluorescence polarization immunoas will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-215698